Bayer's $63 billion purchase in 2018 of seeds and pesticides maker Monsanto was a long-term bet on robust growth in farming ...

Glacier FarmMedia - While mustard growers face many of the same agronomic challenges as canola growers, they often find ...

The chemical giant cut its financial outlook as it faces slowing crop protection sales and regulatory uncertainty around ...

Bayer share price crashed to its lowest level in over twenty years as concerns about its future continued. It plunged to a ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

Bayer's shares plunged to a 20-year low Tuesday after the German chemicals giant cut its earnings outlook and posted a ...

Germany’s Bayer saw its shares tumble almost 11% to 21.76 euros this morning, as it reported level third-quarter 2024 sales ...

Bayer (BAYZF) faces significant risks from litigation and poor M&As. Read why I maintain my buy rating for the stock.

The company has been trying to bolster its pharma pipeline, reduce debt, address U.S. legal cases over weedkiller Roundup, and overhaul its organization in a bid to turn its finances around. Bayer ...

The pharmaceutical company lowered its profit target for 2024 after it posted third-quarter results that fell short of ...

In a crisis, psychologists recommend focusing on factors within our control. Bayer’s chief executive Bill Anderson has duly been focusing on self-help measures such as efficiencies and cost cuts as he ...

The consumer health unit reported higher sales and earnings. Bayer has been dogged in recent years by massive litigation issues linked to the Roundup weedkiller, a problem it inherited in the 2018 ...